IGC Pharma Adds Visionary Investigators Network as Clinical Site to Phase 2 CALMA Trial February 23, 2026 Read More »
IGC Pharma Reports Financial Results and Clinical Progress for the Period Ended December 31, 2025 March 19, 2026 Read More »
IGC Pharma to Showcase AI Platform with Alzheimer’s Disease Data Initiative at ADPD 2026 March 18, 2026 Read More »
